Navigation Links
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
Date:5/7/2008

human, soluble VEGF receptor fusion protein that binds all forms of VEGF-A along with the related placental growth factor (PIGF) and VEGF-B. VEGF Trap-Eye is a specific and highly potent blocker of these growth factors. Blockade of VEGF can prevent abnormal blood vessel formation as well as vascular leak and has proven beneficial in the treatment of wet AMD.

About Wet AMD

Age-related Macular Degeneration (AMD) is a leading cause of acquired blindness. Macular degeneration is diagnosed as either dry (non-exudative) or wet (exudative). In wet AMD, new blood vessels grow beneath the retina and leak blood and fluid. This leakage causes disruption and dysfunction of the retina creating blind spots in central vision, and it can account for blindness in wet AMD patients. Wet AMD is the leading cause of blindness for people over the age of 65 in the U.S. and Europe.

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at http://www.bayerhealthcare.com.

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized mar
'/>"/>

SOURCE Bayer HealthCare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
4. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
5. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Tainted Chinese Food Ingredients First Discovered in 2005
10. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... and SEATTLE , May ... in the development of robotics, sensors and medical devices, ... as the company,s Chief Financial Officer and head of ... experience in corporate development, business development and finance roles, ... Ventures and Pendrell Corporation.  Mr. Woo will be located ...
(Date:5/21/2015)... BERKELEY, Kalifornien, und KOPENHAGEN, Dänemark, 21. Mai ... , ein Weltmarktführer bei der klinischen und ... bekannt, man werde im Rahmen der weltweiten ... ca. 14.000 Liter Produktionskapazität erweitern. ... Kunden erhalten durch das innovative Einweg Bioreactor ...
(Date:5/21/2015)... , May 21, 2015 The ... find applications in pharmaceutical development to help increase ... the coasts associated with drug development, according to ... stage was the part of the process that ... publisher,s report, Lab Automation Markets, 4th Edition ...
Breaking Medicine Technology:Sarcos Corp. Announces Preston Woo as CFO and Head of Corporate Development 2CMC Biologics erweitert GMP-Produktionskapazität in Europa 2CMC Biologics erweitert GMP-Produktionskapazität in Europa 3Kalorama: Growing Use of Robotics in Sample Prep a Key Trend in Medical Lab Automation 2Kalorama: Growing Use of Robotics in Sample Prep a Key Trend in Medical Lab Automation 3Kalorama: Growing Use of Robotics in Sample Prep a Key Trend in Medical Lab Automation 4
... According to new data released by the Centers for Medicare ... prescription drug plan premium is roughly $30, a figure far ... 2003. The premium figure confirms the success of Medicare Part ... Management Association (PCMA) today. "With the help ...
... KANSAS CITY, Mo., Aug. 4, 2011 Purdue ... vital medical antiseptic to Children International , ... around the world. To view the ... http://multivu.prnewswire.com/mnr/childreninternational/46399/ (Photo: ...
Cached Medicine Technology:PCMA: Part D Plans and PBMs Continue to Deliver Savings in Medicare 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 3
(Date:5/21/2015)... (PRWEB) May 21, 2015 World Patent ... products, launches the Troll Motor Guide, a boat patent ... boating. , "The recreational boating industry has reached an ... CEO and Creative Director of World Patent Marketing ... numbers and predicts continued steady growth of seven percent ...
(Date:5/21/2015)... 2015 The Johns Hopkins Alliance for ... Baltimore Commercial Advisory Board has selected a research project ... as one of two $50,000 Abell Foundation Award for ... known as Anklebot. Developed by the VA Maryland ... the University of Maryland School of Medicine and Massachusetts ...
(Date:5/21/2015)... Bird B Gone, the leader in bird control products for ... the Bird Spike 2001 to its comprehensive lineup of bird ... is specifically designed to reduce building maintenance costs by preventing ... I-beams, window ledges and more. It is now available online ... to buy the right amount of spike to get the ...
(Date:5/21/2015)... Many probiotics taken to promote gut ... celiac disease according to a new study by ... tested in the study contained gluten, a protein that ... cause gastrointestinal inflammation for those suffering from celiac disease ... trust in gluten-free claims have turned to global public ...
(Date:5/21/2015)... An existing anti-stroke drug is ... ability to suppress mucus overproduction, improve bacterial clearance ... Georgia State University and the University of Rochester. ... Journal of Immunology, could result in a novel, ... possibly through topical drug delivery. Vinpocetine, the drug ...
Breaking Medicine News(10 mins):Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 2Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 4Health News:Anti-Stroke Drug Effective Treatment for Middle-Ear Infections, Researchers Say 2Health News:Anti-Stroke Drug Effective Treatment for Middle-Ear Infections, Researchers Say 3
... Health Care, Food Service, Financial Services Are Adding Jobs ... Profiles International , the world leader in ... identified clients in several job sectors that continue to ... unique vantage point with clients that continue to seek ...
... Muscle Pharm is proud to announce the signing of UFC ... Supplement Sponsor of Shane Carwin."We are very excited about adding ... a true specimen," said Brad Pyatt, Muscle Pharm President. Shane ... headed into his biggest professional fight of his career March ...
... Cooperative Offers Up Delicious Recipes and Sage Advice ... is National Nutrition Month. In support of the ... on the importance of making informed food choices ... Cabot Creamery Cooperative has developed a host of ...
... evidence revealed about IDSA guidelines, science, researchers examined ... Midwest author, researcher, and Lyme patient PJ Langhoff ... conflicts of interest, academic ties, research, and IDSA ... "The Baker,s Dozen & the Lunatic Fringe: Has ...
... (Nasdaq: ENDO ), an innovative medical device ... used by urologists and interventional radiologists for tissue and ... and year ended December 31, 2008. Highlights of the ... to the fourth quarter of 2007 and the announcement ...
... apply its expertise to the development of an innovative plasma protein ... ... Les Ulis, France (PRWEB) March 6, 2009 -- Thomas Wellner, President ... CEO of LFB S.A. announce that a development services contract has ...
Cached Medicine News:Health News:Unemployment Rises, Profiles International Reveals Who's Hiring 2Health News:Photo: March Forth Into Spring with a Healthy Approach to Diet and Exercise 2Health News:Photo: March Forth Into Spring with a Healthy Approach to Diet and Exercise 3Health News:Photo: March Forth Into Spring with a Healthy Approach to Diet and Exercise 4Health News:New Book Exposes 'Junk Science,' Conflicts of Interest, Disease Guidelines Affecting Millions 2Health News:New Book Exposes 'Junk Science,' Conflicts of Interest, Disease Guidelines Affecting Millions 3Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 2Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 3Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 4Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 5Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 6Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 7Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 8Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 9Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 10Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 11Health News:Therapure Biopharma Inc. and LFB Biotechnologies Announce Development Services Contract for New Therapeutic Protein 2Health News:Therapure Biopharma Inc. and LFB Biotechnologies Announce Development Services Contract for New Therapeutic Protein 3
McPherson curved tying forceps is long has curved shafts with tying platform 4 mm, serrated handle and polished finish. Overall length 110 mm....
Kelman - McPherson tying forceps with serrated handle, platform 4 mm and overall length of 85 mm....
Castroviejo tying forceps, straight....
Moria tying forceps are straight, very delicate platforms for 10-0 and 11-0 monofilament. Platforms fully meet to hold suture firmly....
Medicine Products: